Rifaximin may improve quality of life for IBS-D patients

10/13/2008 | Medscape (free registration)

Data from a Phase II trial show rifaximin may significantly improve quality-of-life symptoms in patients with irritable bowel syndrome with diarrhea. Researchers, presenting at the ACG annual meeting, found that the rifaximin group showed greater improvements over the placebo group in overall quality-of-life scores as well as subscale scores for body image, relationships, dysphoria and health concerns.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA